San Diego-primarily based Viking Therapeutics marked itself as a serious competitor during the weight loss drug industry in February soon after revealing promising knowledge from the mid-phase demo of experimental drug VK2735, which advised it rivaled—and outperformed—Novo and Lilly drugs when presented as a weekly injection and in March the co… Read More